Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Mokhtar R Gomaa"'
Autor:
Mokhtar R Gomaa, Amira S El Rifay, Mahmoud Shehata, Ahmed Kandeil, Mina Nabil Kamel, Mohamed A Marouf, Mohamed GabAllah, Ahmed El Taweel, Ahmed E Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H Mahmoud, Noura M Abo Shama, Mohamed El Sayes, Ahmed Mostafa, Rabeh El-Shesheny, Pamela P McKenzie, Richard J Webby, Ghazi Kayali, Mohamed A Ali
Publikováno v:
PLoS Pathogens, Vol 17, Iss 3, p e1009413 (2021)
SARS-CoV-2 virus is transmitted in closed settings to people in contact with COVID-19 patients such as healthcare workers and household contacts. However, household person-to-person transmission studies are limited. Households participating in an ong
Externí odkaz:
https://doaj.org/article/c3063b40da904e3ab3495d2abddd09b1
Autor:
Wael H Roshdy, Helmy A Rashed, Ahmed Kandeil, Ahmed Mostafa, Yassmin Moatasim, Omnia Kutkat, Noura M Abo Shama, Mokhtar R Gomaa, Ibrahim H El-Sayed, Nancy M El Guindy, Amal Naguib, Ghazi Kayali, Mohamed A Ali
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241739 (2020)
Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVI
Externí odkaz:
https://doaj.org/article/ea6ea7441c6f4d55858372e248ee6e83
Autor:
Ahmed Kandeil, Mokhtar R Gomaa, Ahmed El Taweel, Ahmed Mostafa, Mahmoud Shehata, Ahmed E Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H Mahmoud, Mina Nabil Kamel, Noura M Abo Shama, Mohamed El Sayes, Rabeh El-Shesheny, Mahmoud A Yassien, Richard J Webby, Ghazi Kayali, Mohamed A Ali
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241471 (2020)
Anecdotal evidence showed a negative correlation between Bacille Calmette-Guérin (BCG) vaccination and incidence of COVID-19. Incidence of the disease in children is much lower than in adults. It is hypothesized that BCG and other childhood vaccinat
Externí odkaz:
https://doaj.org/article/fb451ddcecf845c6979906a9d175756b
Autor:
Mohamed A Ali, Mahmoud M Shehata, Mokhtar R Gomaa, Ahmed Kandeil, Rabeh El-Shesheny, Ahmed S Kayed, Ahmed N El-Taweel, Mohamed Atea, Nagla Hassan, Ola Bagato, Yassmin Moatasim, Sara H Mahmoud, Omnia Kutkat, Asmaa M Maatouq, Ahmed Osman, Pamela P McKenzie, Richard J Webby, Ghazi Kayali
Publikováno v:
Emerging Microbes and Infections, Vol 6, Iss 1, Pp 1-7 (2017)
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe human infections and dromedary camels are considered an intermediary host. The dynamics of natural infection in camels are not well understood. Through systematic surveillance in E
Externí odkaz:
https://doaj.org/article/95f486af5eb54ffdb594d09f71481252
Autor:
Mokhtar R Gomaa, Ahmed Kandeil, Ahmed S Kayed, Mona A Elabd, Shaimaa A Zaki, Dina Abu Zeid, Amira S El Rifay, Adel A Mousa, Mohamed M Farag, Pamela P McKenzie, Richard J Webby, Mohamed A Ali, Ghazi Kayali
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0155294 (2016)
Avian influenza viruses circulate widely in birds, with occasional human infections. Poultry-exposed individuals are considered to be at high risk of infection with avian influenza viruses due to frequent exposure to poultry. Some avian H7 viruses ha
Externí odkaz:
https://doaj.org/article/618dff2c2c104c0487b858154dfed02f
Autor:
Mokhtar R. Gomaa, Amira S. El Rifay, Dina Abu Zeid, Mona A. Elabd, Eman Elabd, Ahmed Kandeil, Noura M. Abo Shama, Mina N. Kamel, Mohamed A. Marouf, Ahmed Barakat, Samir Refaey, Amal Naguib, Pamela P. McKenzie, Richard J. Webby, Mohamed A. Ali, Ghazi Kayali
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 9, Pp 2129-2136 (2020)
Currently enzootic avian influenza H5N1, H9N2, and H5N8 viruses were introduced into poultry in Egypt in 2006, 2011, and 2016, respectively. Infections with H5N1 and H9N2 were reported among poultry-exposed humans. We followed 2,402 persons from hous
Externí odkaz:
https://doaj.org/article/8f253971c4d842ac83db4c8400072d7a
Autor:
Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Wael H. Roshdy, Ahmed Kandeil, Richard J. Webby, Ghazi Kayali, Mohamed A. Ali
Publikováno v:
Vaccine. 40:4303-4306
The diversity of SARS-CoV-2 continues to lead to the emergence of new SARS-CoV-2 variants. SARS-CoV-2 antibody assays are crucial in managing the COVID-19 pandemic by determining the neutralizing antibody response. This study aims to investigate vacc
Autor:
Ahmed Kandeil, Ahmed Mostafa, Rehab R. Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Mahmoud Shehata, Marawan A. Elbaset, Ahmed E. Kayed, Sara H. Mahmoud, Yassmin Moatasim, Omnia Kutkat, Noha N. Yassen, Marwa E. Shabana, Mohamed GabAllah, Mina Nabil Kamel, Noura M. Abo Shama, Mohamed El Sayes, Amira N. Ahmed, Zahraa S. Elalfy, Bassim MSA Mohamed, Safa N. Abd El-Fattah, Hazem Mohamed El Hariri, Mona Abdel Kader, Osama Azmy, Ghazi Kayali, Mohamed A. Ali
Publikováno v:
Vaccines, Vol 9, Iss 3, p 214 (2021)
Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in clinical development and 173 are in the pre-clinical phase. Five types of vaccines are currently approved for emergency use in many countries (Inactivated, Sinopharm;
Externí odkaz:
https://doaj.org/article/16f183606c1f4285b2d3c5e5027ad362
Autor:
Mokhtar R. Gomaa, Rebecca Badra, Amira S. El Rifay, Ahmed Kandeil, Mina N. Kamel, Noura M. Abo Shama, Rabeh El‐Shesheny, Ahmed B. Barakat, Mohamed A. Ali, Ghazi Kayali
Publikováno v:
Influenza and Other Respiratory Viruses. 16:749-755
H1N1 and H3N2 influenza A viruses circulate in people as seasonal influenza viruses. Data on influenza infection rates and circulation in demographic subpopulations in Egypt are limited. In this study, we aimed to determine the incidence and seroprev
Autor:
Samah A. Loutfy, Ahmed I. Abdel-Salam, Yassmin Moatasim, Mokhtar R. Gomaa, Nasra F. Abdel Fattah, Merna H. Emam, Fedaa Ali, Hasnaa A. ElShehaby, Eman A. Ragab, Hanaa M. Alam El-Din, Ahmed Mostafa, Mohamed A. Ali, Amal Kasry
Publikováno v:
RSC Advances. 12:15775-15786
To develop a specific treatment against COVID-19, we investigated silymarin–chitosan nanoparticles (Sil–CNPs) as an antiviral agent against SARS-CoV-2 using in silico and in vitro approaches.